ArticleAmerican journal of ophthalmology case reports2025
High-resolution optical coherence tomography in pathology of the vitreomacular interface.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-Resolution Optical Coherence Tomography Visualizes Posterior Vitreous Lamellar Architecture in Eyes With Chronic Central Serous Chorioretinopathy.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study investigates the diagnostic capabilities of high-resolution optical coherence tomography (HR-OCT) compared to spectral domain optical coherence tomography (SD-OCT) in detecting detailed microstructural changes in vitreomacular pathology. Methods: This was a prospective cross-sectional study of eyes with vitreomacular interface disease. We included patients with epiretinal membrane (ERM), macular hole (MH), lamellar hole (LH), and vitreomacular traction (VMT). Each patient underwent a comprehensive ophthalmic exam followed by retinal imaging with both SD-OCT and HR-OCT. Images were analyzed for the presence of key biomarkers and the two OCT modalities were compared. Results: The study cohort consisted of 18 patients with a mean age of 66 years (SD 8.9) and (61.1 %) had biological male sex. HR-OCT provided a superior subcellular view, including superior identification of rod cell nuclei in the outer nuclear layer (ONL) and ganglion cell layer (GCL) and enhanced visualization of biomarkers such as the "cotton ball sign" coupled with IZ disruption (33.3 % vs 5.6 % for HR-OCT and SD-OCT groups, respectively, p = 0.0042). Hyporeflective dots in the ONL, indicative of rod cell nuclei, were seen in 88.9 % of HR-OCT cases but were completely undetectable with SD-OCT (p < 0.0001). Inter-grader reliability was strong, with Cohen's Kappa values for most biomarkers ranging from 0.78 to 0.89. Conclusions: HR-OCT significantly improves the detection of subcellular features and biomarkers in vitreomacular interface disorders. This device could enhance early diagnosis and monitoring of vitreomacular diseases, with potential correlations to functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.